Amended Safety Assessment of Parabens As Used in Cosmetics

Total Page:16

File Type:pdf, Size:1020Kb

Amended Safety Assessment of Parabens As Used in Cosmetics Amended Safety Assessment of Parabens as Used in Cosmetics Status: Draft Final Amended Report for Panel Review Release Date: March 15, 2019 Panel Meeting Date: April 8-9, 2019 The 2019 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth, Ph.D. This report was prepared by Jinqiu Zhu, Ph.D., Toxicologist. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 [email protected] Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 MEMORANDUM To: CIR Expert Panel and Liaisons From: Jinqiu Zhu, PhD, DABT, ERT Toxicologist Date: March 15, 2019 Subject: Draft Final Amended Safety Assessment of Parabens as Used in Cosmetics Attached is the Draft Final Amended Report of 20 parabens and 4-Hydroxybenzoic Acid, as used in cosmetics (parabe042019FAR). At the September 2018 meeting, the Panel issued a tentative amended report for public comment with the conclusion that the following 20 ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment. Butylparaben Potassium Ethylparaben* Sodium Isobutylparaben Calcium Paraben* Potassium Methylparaben* Sodium Isopropylparaben* Ethylparaben Potassium Paraben* Sodium Methylparaben Isobutylparaben Potassium Propylparaben* Sodium Paraben* Isopropylparaben Propylparaben Sodium Propylparaben Methylparaben Sodium Butylparaben 4-Hydroxybenzoic Acid* Potassium Butylparaben* Sodium Ethylparaben * Not reported to be in current use. Were the ingredient in this group not in current use to be used in the future, the expectation is that it would be used in product categories and at concentrations comparable to others in this group. The Panel also determined that the available data are insufficient to determine the safety of Benzylparaben. The data needed to determine safety of this ingredient comprise a no-observed-adverse-effect-level (NOAEL) derived from developmental and reproductive toxicity (DART) studies. This ingredient is not reported to be in use. The Panel discussed concerns about the bioaccumulation potential of parabens. The Panel noted that recent studies with sensitive analytical methods have demonstrated the presence of parabens in various human tissues. However, the data are equivocal regarding cumulative storage in such tissues; and importantly, the available evidence suggests no significant association of parabens exposure with diseases or other adverse health conditions. The Panel also noted that refined aggregate exposure models suggest that cosmetic product use is a major source of parabens exposure. However, the vast quantity of biomonitoring data indicates that systemic exposure to these ingredients is very low. __________________________________________________________________________________________ 1620 L Street, NW Suite 1200, Washington, DC 20036 (Main) 202-331-0651 (Fax) 202-331-0088 (Email) [email protected] (Website) www.cir-safety.org Distributed for Comment Only -- Do Not Cite or Quote The Panel discussed the safety of parabens as used in vaginally-applied cosmetic products. The Panel classified the currently available studies as illustrations of potential, general hazards, which fail to demonstrate risks relevant to cosmetic safety in the context of concentration of use. The Panel’s deliberations on the draft assessment report comprised extensive revisions to better identify, and explain the rationale for, the values utilized in conducting the risk assessment therein. The Panel further requested that the margin of safety (MOS) should be re-calculated, weighing the different use concentrations and exposures of Butylparaben in various cosmetic products category. The report was revised accordingly. Since the September meeting, additional data on biomonitoring, endocrine activity, dermal sensitization and epidemiological studies have been incorporated into the report. The input of new studies as well as discussions regarding bioaccumulation, dermal absorption rate, and Physiologically Based Pharmacokinetic (PBPK) Model for the estimating the internal exposure of parabens, are highlighted within the text of this report. Also included in this package for review are the CIR report history (parabe042019hist), flow chart (parabe042019flow), literature search strategy (parabe042019strat), ingredient data profile (parabe042019prof), and previous meeting transcripts (parabe042019min). Comments provided by the Council prior to the September meeting and on the tentative amended report have been addressed (parabe042019pcpc1 and parabe042019pcpc2, respectively). The Panel should carefully review the Abstract, Discussion, and Conclusion of this report. If these are satisfactory, the Panel should issue a final amended report. __________________________________________________________________________________________ 1620 L Street, NW Suite 1200, Washington, DC 20036 (Main) 202-331-0651 (Fax) 202-331-0088 (Email) [email protected] (Website) www.cir-safety.org Distributed for Comment Only -- Do Not Cite or Quote RE-REVIEW FLOW CHART INGREDIENT/FAMILY___Parabens______________________________________________________ MEETING _______ April 2019_________________________________________________________ Public Comment CIR Expert Panel Re-Review Rpt Status ; or New Data Sodium Methylparaben announce 15 years OR request since last was included on the review 2017 Priority List due to frequency of use Re-review to Panel PRIORITY LIST June 2017 led to RR of IJT 27 (Suppl Are new data cause to reopen? June 2017: RR was re-opened because 4):1- 82; 2008 of new data, and additional ingredients were added. Pending rpt was then (3 previous reports exist) tabled for SME review of DART data. Mar 2018: DART presentation; no YES decision made NO DRAFT AMENDED REPORT DAR June 2017; Mar 2018 Are new ingredients appropriate for inclusion/re-open? 13 add-ons Table Tabled IDA TAR June 2017 mtg Yes No IDA Notice IDA RE-REVIEW Admin Book DRAFT TENTATIVE SUMMARY Draft TAR AMENDED REPORT Sept 2018 Table Table Tentative Amended Report Jan 23, 2019 Issue TAR Draft FAR DRAFT FINAL 60 day Public comment period AMENDED REPORT Apr 2019 Table Table Different Conclusion Final Amended Issue PUBLISH Report FAR Distributed for Comment Only -- Do Not Cite or Quote CIR History of: Parabens 1984 – Report published for Methylparaben, Ethylparaben, Propylparaben, and Butylparaben with the conclusion that these ingredients are safe as cosmetic ingredients in the present practices of use. 1986 – Report on Benzylparaben was published with an insufficient data conclusion. The data needs were: 1. UV absorption spectrum. If absorption occurs between 280 and 360 nm, a photosensitization study is required (in animals only, not in clinical assays). 2. Data detailing the possible presence of impurities. 3. Subchronic feeding study-90-day in rats. 4. Mutagenicity studies and/or in vitro assays for genotoxicity. 5. Eye irritation study at concentration of use. 6. Metabolism and associated pharmacokinetic studies are not requested at this time. If significant toxicity is shown in the above tests, the Expert Panel may request this additional type of testing. 1995 – Report on Isobutylparaben and Isopropylparaben was published with a conclusion of safe as cosmetic ingredients in the present practices of use. 2008 – Amended report published. The ingredients in the three previous reports are included. The Conclusion was that these ingredients are safe as cosmetic ingredients in the present practices of use. “The CIR Expert Panel considered exposures to cosmetic products containing a single parabens preservative (use level of 0.4%) separately from products containing multiple parabens (use level of 0.8%) and infant exposures separately from adult exposures in determining margins of safety (MOS). The MOS for infants ranged from ~6000 for single paraben products to ~3000 for multiple paraben products. The MOS for adults ranged from 1690 for single paraben products to 840 for multiple paraben products. The Expert Panel considers that these MOS determinations are conservative and likely represent an overestimate of the possibility of an adverse effect (e.g., use concentrations may be lower, penetration may be less) and support the safety of cosmetic products in which parabens preservatives are used.” March 2012 – “The Panel reaffirmed the safety of parabens as preservatives in the present practices of use and concentration in cosmetics. At the request of the Personal Care Products Council, the Panel re-examined its 2008 published safety assessment of parabens. The Council cited new opinions from the European Commission’s Scientific Committee on Consumer Safety (SCCS) regarding (1) safe levels of parabens in cosmetics and (2) parabens in products intended for children under 3 years of age. The SCCS updated opinion on parabens confirmed that methyl- and ethylparaben are safe up to 0.4% for one and a total of 0.8% for any mixture, but lowered the level in cosmetics considered safe for propyl- and butylparaben to 0.19% for any one or any mixture. This lowering appeared to be based on a re-evaluation of existing dermal penetration/metabolism data, not on new data. The Panel reiterated its very conservative
Recommended publications
  • Water Quality Testing Summary
    WATER QUALITY TESTING SUMMARY A DETAILED REVIEW OF THE TEST RESULTS FOR THE DRINKING WATER PRODUCED BY THE CARY/APEX WATER TREATMENT FACILITY 2020 JOHN CONLEY (Senior Laboratory Analyst) has been employed by the Town of Cary at the Cary/Apex Water Treatment Facility Laboratory since September 2001. CARY/APEX WATER TREATMENT FACILITY 2020 WATER QUALITY TESTING SUMMARY We are pleased to present to you the Cary/ If you have any questions or concerns regarding this Apex Water Treatment Facility Test Result report, please contact Rachel Monschein, Water System Summary for 2020. This report is a snapshot of last Laboratory Supervisor, at (919) 362-5507. year’s water quality. The values contained in this report In order to ensure that tap water is safe to drink, EPA are based on single measurements or yearly averages depending on the contaminant. The Environmental prescribes regulations that limit the amount of certain Protection Agency and/or the State requires us to contaminants in water provided by public water systems. monitor for certain substances less than once per year Drinking water, including bottled water, may reasonably because the concentrations of these substances are not be expected to contain at least small amounts of some expected to vary significantly from year to year. Some of contaminants. The presence of contaminants does not the data, though representative of the water quality, is necessarily indicate the water poses a health risk. To obtain more than one year old. In these cases, the most recent more information about contaminants and potential data is included, along with the year in which the sample health effects, call the EPA’s Safe Drinking Water Hotline was taken.
    [Show full text]
  • Structure-Activity Relationships for Bergenin Analogues As Β-Secretase
    Journal of Oleo Science Copyright ©2013 by Japan Oil Chemists’ Society J. Oleo Sci. 62, (6) 391-401 (2013) Structure-activity Relationships for Bergenin Analogues as β-Secretase (BACE1) Inhibitors Yusei Kashima and Mitsuo Miyazawa* Department of Applied Chemistry, Faculty of Science and Engineering, Kinki University (3-4-1, Kowakae, Higashiosaka-shi, Osaka 577-8502, JAPAN) Abstract: Here we evaluated the inhibitory effects of bergenin analogues (2-10), prepared from naturally occurring bergenin, (1) on β-secretase (BACE1) activity. All the bergenin analogues that were analyzed inhibited BACE1 in a dose-dependent manner. 11-O-protocatechuoylbergenin (5) was the most potent inhibitor, with an IC50 value of 0.6 ± 0.07 mM. The other bergenin analogues, in particular, 11-O-3′,4′- dimethoxybenzoyl)-bergenin (6), 11-O-vanilloylbergenin (7), and 11-O-isovanilloylbergenin (8), inhibited BACE1 activity with IC50 values of <10.0 mM. BACE1 inhibitory activity was influenced by the substituents of the benzoic acid moiety. To the best of our knowledge, this is the first report on the structure-activity relationships (SAR) in the BACE1 inhibitory activities of bergenin analogues. These bergenin analogues may be useful in studying the mechanisms of Alzheimer’s disease. Key words: bergenin, bergenin analogues, β-secretase, antioxidant activity, structure-activity relationships 1 INTRODUCTION in adult mice was without any significant effect on brain Alzheimer’s diseas(e AD)is a neurodegenerative disorder, neuregulin processing9), indicating that BACE1 inhibitors with symptoms such as memory loss and disruption in could be established as therapeutic targets for AD. judging, reasoning, and emotional stability. AD is pathologi- Oxidative stress also a cause of AD has been proposed to cally characterized by the accumulation of senile plaques, contribute to Aβ generation and the formation of NFT10).
    [Show full text]
  • Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies
    Molecules 2010, 15, 7985-8005; doi:10.3390/molecules15117985 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies Shahriar Khadem * and Robin J. Marles Natural Health Products Directorate, Health Products and Food Branch, Health Canada, 2936 Baseline Road, Ottawa, Ontario K1A 0K9, Canada * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-613-954-7526; Fax: +1-613-954-1617. Received: 19 October 2010; in revised form: 3 November 2010 / Accepted: 4 November 2010 / Published: 8 November 2010 Abstract: Among the wide diversity of naturally occurring phenolic acids, at least 30 hydroxy- and polyhydroxybenzoic acids have been reported in the last 10 years to have biological activities. The chemical structures, natural occurrence throughout the plant, algal, bacterial, fungal and animal kingdoms, and recently described bioactivities of these phenolic and polyphenolic acids are reviewed to illustrate their wide distribution, biological and ecological importance, and potential as new leads for the development of pharmaceutical and agricultural products to improve human health and nutrition. Keywords: polyphenols; phenolic acids; hydroxybenzoic acids; natural occurrence; bioactivities 1. Introduction Phenolic compounds exist in most plant tissues as secondary metabolites, i.e. they are not essential for growth, development or reproduction but may play roles as antioxidants and in interactions between the plant and its biological environment. Phenolics are also important components of the human diet due to their potential antioxidant activity [1], their capacity to diminish oxidative stress- induced tissue damage resulted from chronic diseases [2], and their potentially important properties such as anticancer activities [3-5].
    [Show full text]
  • 01 Excipients Prelims 1..9
    Ethylparaben 1 Nonproprietary Names BP: Ethyl Hydroxybenzoate SEM 1: Excipient: ethylparaben; magnification: 600Â. JP: Ethyl Parahydroxybenzoate PhEur: Ethyl Parahydroxybenzoate E USP-NF: Ethylparaben 2 Synonyms Aethylum hydrobenzoicum; CoSept E; E214; ethylis parahydroxy- benzoas; ethyl p-hydroxybenzoate; Ethyl parasept; 4-hydroxyben- zoic acid ethyl ester; Nipagin A; Solbrol A; Tegosept E; Uniphen P- 23. 3 Chemical Name and CAS Registry Number Ethyl-4-hydroxybenzoate [120-47-8] 4 Empirical Formula and Molecular Weight C9H10O3 166.18 5 Structural Formula SEM 2: Excipient: ethylparaben; magnification: 3000Â. 6 Functional Category Antimicrobial preservative. 7 Applications in Pharmaceutical Formulation or Technology Ethylparaben is widely used as an antimicrobial preservative in cosmetics,(1) food products, and pharmaceutical formulations. It may be used either alone or in combination with other paraben esters or with other antimicrobial agents. In cosmetics it is one of the most frequently used preservatives. The parabens are effective over a wide pH range and have a broad spectrum of antimicrobial activity, although they are most effective against yeasts and molds; see Section 10. Owing to the poor solubility of the parabens, paraben salts, particularly the sodium salt, are frequently used. However, this may cause the pH of poorly buffered formulations to become more alkaline. See Methylparaben for further information. 8 Description Ethylparaben occurs as a white, odorless or almost odorless, active against yeasts and molds than against bacteria. They crystalline powder. are also more active against Gram-positive than against Gram-negative bacteria. 9 Pharmacopeial Specifications The activity of the parabens increases with increasing chain See Table I. See also Section 18. length of the alkyl moiety, but solubility decreases.
    [Show full text]
  • Plant Phenolics: Bioavailability As a Key Determinant of Their Potential Health-Promoting Applications
    antioxidants Review Plant Phenolics: Bioavailability as a Key Determinant of Their Potential Health-Promoting Applications Patricia Cosme , Ana B. Rodríguez, Javier Espino * and María Garrido * Neuroimmunophysiology and Chrononutrition Research Group, Department of Physiology, Faculty of Science, University of Extremadura, 06006 Badajoz, Spain; [email protected] (P.C.); [email protected] (A.B.R.) * Correspondence: [email protected] (J.E.); [email protected] (M.G.); Tel.: +34-92-428-9796 (J.E. & M.G.) Received: 22 October 2020; Accepted: 7 December 2020; Published: 12 December 2020 Abstract: Phenolic compounds are secondary metabolites widely spread throughout the plant kingdom that can be categorized as flavonoids and non-flavonoids. Interest in phenolic compounds has dramatically increased during the last decade due to their biological effects and promising therapeutic applications. In this review, we discuss the importance of phenolic compounds’ bioavailability to accomplish their physiological functions, and highlight main factors affecting such parameter throughout metabolism of phenolics, from absorption to excretion. Besides, we give an updated overview of the health benefits of phenolic compounds, which are mainly linked to both their direct (e.g., free-radical scavenging ability) and indirect (e.g., by stimulating activity of antioxidant enzymes) antioxidant properties. Such antioxidant actions reportedly help them to prevent chronic and oxidative stress-related disorders such as cancer, cardiovascular and neurodegenerative diseases, among others. Last, we comment on development of cutting-edge delivery systems intended to improve bioavailability and enhance stability of phenolic compounds in the human body. Keywords: antioxidant activity; bioavailability; flavonoids; health benefits; phenolic compounds 1. Introduction Phenolic compounds are secondary metabolites widely spread throughout the plant kingdom with around 8000 different phenolic structures [1].
    [Show full text]
  • A Critical Study on Chemistry and Distribution of Phenolic Compounds in Plants, and Their Role in Human Health
    IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT) e-ISSN: 2319-2402,p- ISSN: 2319-2399. Volume. 1 Issue. 3, PP 57-60 www.iosrjournals.org A Critical Study on Chemistry and Distribution of Phenolic Compounds in Plants, and Their Role in Human Health Nisreen Husain1, Sunita Gupta2 1 (Department of Zoology, Govt. Dr. W.W. Patankar Girls’ PG. College, Durg (C.G.) 491001,India) email - [email protected] 2 (Department of Chemistry, Govt. Dr. W.W. Patankar Girls’ PG. College, Durg (C.G.) 491001,India) email - [email protected] Abstract: Phytochemicals are the secondary metabolites synthesized in different parts of the plants. They have the remarkable ability to influence various body processes and functions. So they are taken in the form of food supplements, tonics, dietary plants and medicines. Such natural products of the plants attribute to their therapeutic and medicinal values. Phenolic compounds are the most important group of bioactive constituents of the medicinal plants and human diet. Some of the important ones are simple phenols, phenolic acids, flavonoids and phenyl-propanoids. They act as antioxidants and free radical scavengers, and hence function to decrease oxidative stress and their harmful effects. Thus, phenols help in prevention and control of many dreadful diseases and early ageing. Phenols are also responsible for anti-inflammatory, anti-biotic and anti- septic properties. The unique molecular structure of these phytochemicals, with specific position of hydroxyl groups, owes to their powerful bioactivities. The present work reviews the critical study on the chemistry, distribution and role of some phenolic compounds in promoting health-benefits.
    [Show full text]
  • Hydroxybenzoic Acid Isomers and the Cardiovascular System Bernhard HJ Juurlink1,2, Haya J Azouz1, Alaa MZ Aldalati1, Basmah MH Altinawi1 and Paul Ganguly1,3*
    Juurlink et al. Nutrition Journal 2014, 13:63 http://www.nutritionj.com/content/13/1/63 REVIEW Open Access Hydroxybenzoic acid isomers and the cardiovascular system Bernhard HJ Juurlink1,2, Haya J Azouz1, Alaa MZ Aldalati1, Basmah MH AlTinawi1 and Paul Ganguly1,3* Abstract Today we are beginning to understand how phytochemicals can influence metabolism, cellular signaling and gene expression. The hydroxybenzoic acids are related to salicylic acid and salicin, the first compounds isolated that have a pharmacological activity. In this review we examine how a number of hydroxyphenolics have the potential to ameliorate cardiovascular problems related to aging such as hypertension, atherosclerosis and dyslipidemia. The compounds focused upon include 2,3-dihydroxybenzoic acid (Pyrocatechuic acid), 2,5-dihydroxybenzoic acid (Gentisic acid), 3,4-dihydroxybenzoic acid (Protocatechuic acid), 3,5-dihydroxybenzoic acid (α-Resorcylic acid) and 3-monohydroxybenzoic acid. The latter two compounds activate the hydroxycarboxylic acid receptors with a consequence there is a reduction in adipocyte lipolysis with potential improvements of blood lipid profiles. Several of the other compounds can activate the Nrf2 signaling pathway that increases the expression of antioxidant enzymes, thereby decreasing oxidative stress and associated problems such as endothelial dysfunction that leads to hypertension as well as decreasing generalized inflammation that can lead to problems such as atherosclerosis. It has been known for many years that increased consumption of fruits and vegetables promotes health. We are beginning to understand how specific phytochemicals are responsible for such therapeutic effects. Hippocrates’ dictum of ‘Let food be your medicine and medicine your food’ can now be experimentally tested and the results of such experiments will enhance the ability of nutritionists to devise specific health-promoting diets.
    [Show full text]
  • Sccs/1404/11
    SCCS/1404/11 EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Risk assessment Scientific Committee on Consumer Safety 9th plenary Meeting Held on 14 December 2010 in Brussels MINUTES 1. WELCOME AND APOLOGIES The chairman of the SCCS welcomed all the participants. Apologies were received from Dr. Q. Chaudry, Dr. S.C. Rastogi, Prof. K. Savolainen and Dr. R. Waring. 2. DECLARATIONS OF INTEREST No member declared any interest that could prevent him/her from participating in the discussion of the items on the agenda. 3. APPROVAL OF THE DRAFT AGENDA SCCS/1388/10 The agenda was approved without changes. 4. ADOPTION OF THE DRAFT MINUTES OF THE 8TH PLENARY MEETING SCCS/1379/10 The minutes of the 8th plenary meeting of 21 September 2010 were approved. 5. INFORMATION FROM CHAIRMAN/MEMBERS Information from the Chairman No issues were raised. Commission follow-up to earlier opinions In the absence of a representative of SANCO Unit B2 - Cosmetics and Medical Devices – the secretariat said that no legal implementations for cosmetic ingredients were made since the last plenary of 21 September 2010. 6. NEW REQUESTS 6.1. SCCS New requests were received for Zinc oxide (nano-size), ethyl lauroyl arginate (P95) and for Benzisothiazolinone (P96). SCCS/1404/11 Minutes 9th plenary meeting of the SCCS of 14 December 2010 ___________________________________________________________________________________________ 6.2. Mandates for other / all Committees / 7. REPORTS FROM THE WORKING GROUPS 7.1. Cosmetic Ingredients The Chairperson of the WG reported on the ongoing work. Draft opinions on parabens (P82), dihydroxyacetone (DHA) and on trisodium nitrilotriacetate (NTA) were prepared and tabled for formal adoption.
    [Show full text]
  • Smart Innovation
    Smart Innovation THE OPPORTUNITY FOR SAFER PRESERVATIVES ABOUT ENVIRONMENTAL DEFENSE FUND The goal of the health program at Environmental Defense Fund (EDF) is to improve human and ecological health through reductions in exposure to harmful chemicals and pollution. EDF’s health program uses the dual levers of public policy and corporate leadership to phase harmful substances and practices out of the market and introduce safer products and practices into mainstream use. We encourage and support innovations that work toward this end. ABOUT THIS REPORT The Preservative Innovation Project (PIP) offers a framework to direct innovation for specific functional classes of chemicals (e.g., preservatives) in order to drive safer chemicals and products into the marketplace. The primary output of the framework is a uniformly-developed, baseline set of toxicological information for a representative set of chemicals in a functional class. Such baseline toxicological information can be used to inform design criteria for new chemical research and development (R&D); provide a basis of toxicological comparison for new chemicals entering the market; and direct additional chemical testing and research where data are lacking or insufficient. The PIP was led by the Environmental Defense Fund, with input from The PIP was led by Environmental Defense Fund, with input from several companies including Active Micro Technologies, Beautycounter, Clariant, and Seventh Generation as well as the Green Chemistry and Commerce Council. However, EDF is the sole author of this report. Organizations that provided input into its development should not be interpreted as endorsers of the content. This report describes the PIP framework, and the findings and conclusions drawn from the toxicological evaluation of a subset of commercially available preservatives.
    [Show full text]
  • Preserving the Faith a Cosmetic Formulators Overview John Woodruff John Woodruff: the Personal Stuff
    Preserving the faith A cosmetic formulators overview John Woodruff www.creative-developments.co.uk John Woodruff: the personal stuff 1960: joined Smith & Nephew Research 1976: Co-founded Pava, responsible for all technical aspects, from formulation and development to manufacture and filling and originated many well-known brands. October 1988: Established consulting laboratory for formulation of cosmetics and toiletry products. Developed Creativity a unique programme written for formula creation and cosmetic manufacture Two books and many articles published on cosmetic technology. Twice appeared as an expert witness, 3 times Chairman of the European UV & Sun Filters Conference, Twice chaired a technical session at In-Cosmetics 1990 – 1996: Cosmetics Consultant to Manufacturing Chemist 1996 – Present: Regular contributions to Soap, Perfumery and Cosmetics (SPC) Supports the Distance Leaning Course run by the SCS Lectures on product formulation at the Principles and Practice of Cosmetic Science When he is not working he is sailing. 2 The cosmetic product brief • Product type • Claims • Product format • Application • Texture • Colour • Perfume • Packaging • Cost 3 What about the preservative? Preservatives are one of the last things that most chemists think about when formulating a product and one of the first things that are suspected when a problem occurs. They are important ingredients, the value of which is never noticed when functioning properly and which are worthless when not. Preservatives are much maligned and misunderstood within the cosmetics industry. Because of this, they are often over-dosed, under-dosed or improperly formulated even by experienced chemists Cosmetic formulations require a delicate balance of a large number of raw materials.
    [Show full text]
  • Exposure to and Toxicity of Methyl-, Ethyl- and Propylparaben a Literature Review with a Focus on Endocrine-Disrupting Properties
    National Institute forPublic Health and the Environment Ministryof Health, Welfare and Sport Exposure to and toxicity of methyl-, ethyl- and propylparaben A literature review with a focus on endocrine-disrupting properties RIVM Report 2017-0028 W. Brand et al. Exposure to and toxicity of methyl-, ethyl- and propylparaben A literature review with a focus on endocrine-disrupting properties RIVM Report 2017-0028 RIVM Report 2017-0028 Colophon © RIVM 2018 Parts of this publication may be reproduced, provided acknowledgement is given to: National Institute for Public Health and the Environment, along with the title and year of publication. DOI 10.21945/RIVM-2017-0028 W. Brand (author), RIVM P.E. Boon (author), RIVM E.V.S. Hessel (author), RIVM J.A.J. Meesters (author), RIVM M. Weda (author), RIVM A.G. Schuur (author), RIVM Contact: dr.ir. Walter Brand Centre for Safety of Substances and Products [email protected] This investigation has been performed by order and for the account of The Netherlands Food and Consumer Product Safety Authority (NVWA), within the framework of research question 9.1.67 ‘Exposure of consumers to substances with possible effects on the endocrine system’. This is a publication of: National Institute for Public Health and the Environment P.O. Box 1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 109 RIVM Report 2017-0028 Synopsis Exposure to and toxicity of methyl-, ethyl- and propylparaben A literature review with a focus on endocrine-disrupting properties Parabens inhibit the growth of fungi and bacteria and, as such, are substances that can be used as preservatives in a variety of consumer products, such as personal care products, food and medicines.
    [Show full text]
  • Ryan M. Menapace
    DETERMINATION OF THE EFFECT OF CYCLOHEXYLMETHYLPARABEN ON ACTIVATION OF APOPTOTIC CASPASE-3 IN M624 MELANOMA CELLS Ryan M. Menapace This thesis is submitted in partial fulfillment of the requirements of the Research Honors Program in the Department of Chemistry and Biochemistry Marietta College Marietta, Ohio May 6, 2020 Menapace 1 This Research Honors thesis has been approved for the Department of Chemistry and Biochemistry and the Honors and Investigative Studies Committee by Suzanne Parsons 5/6/2020 Faculty thesis advisor Date David Brown______________________ 5/6/2020 Thesis committee member Date Menapace 2 Foreword Due to the outbreak of COVID-19, work on this project came to an abrupt end before additional caspase-3 activity assays could be completed in triplicate with statistical significance. Data associated with the caspase-3 activity assays is representative of 2 individual sets of data. The inability to receive additional materials for assays from the manufacturer and the suspension of all academic activities at Marietta College have limited the conclusions to this study, but the data presented is as accurate and thorough as possible under the given circumstances. Menapace 3 Acknowledgements This project would not have been possible without the support of Marietta College’s Department of Chemistry and Biochemistry in addition to the support of the Honors Program and Investigative Studies Program. The resources provided by all of these programs were vital to the completion of my project. The knowledge I obtained throughout my education in biochemistry and chemistry were invaluable tools for this process. Special thanks to Dr. David Brown for serving on my thesis committee and providing insight on my project throughout its completion.
    [Show full text]